Day One: 13th March 2006
	Small-Cap Listed Company Presentations
	Ballroom Foyer: SMALL CAP LISTED COMPANIES Chair: Dr Andrew McDonald, Think Equity	Venetian Room: SMALL CAP LISTED COMPANIES Chair: Stephen Muniz, Edwards, Angell, Palmer & Dodge	Ballroom: SMALL CAP LISTED COMPANIES Chair: Charles Baltic III, Wachovia Securities
11:25 AM	Biophan Technologies Michael Weiner, Chief Executive Officer	Diamyd Medical Anders Essen-Moller, Chief Executive Officer	EXACT Sciences Don Hardison, President & CEO
11:40 AM	Swiss Medica Raghu Kilambi, Chief Executive Officer & Founder	Evolutec Mark Carnegie Brown, Chief Executive Officer	Chemokine Dr Hassan Salari, President & CEO
11:55 AM	BioSante Pharmaceuticals Stephen Simes, President & CEO	Transport Pharmaceuticals Dennis Goldberg, President & COO	Chelsea Therapeutics Dr Simon Pedder, Chief Executive Officer
12:10 PM	Morphosys Dave Lemus, Chief Financial Officer	BioMS Medical Corporation Kevin Giese, President & CEO	IBEX Technologies Paul Baehr, President & CEO
12:25 PM	VioQuest Pharmaceuticals Daniel Greenleaf, President & CEO	Matritech Stephen Chubb, Chairman & CEO	Liponex Bill Dickie, President & CEO
	Company Presentations
	Ballroom Foyer: IMMUNOLOGY/ONCOLOGY Chair: Stan Yakatan, Katan Associates	Venetian Room: THERAPEUTICS Chair: Gert Caspritz, Techno Venture Management	Ballroom: SMALL CAP LISTED COMPANIES Chair: Robert Wotzyak, The American Stock Exchange
3:50 PM	ESBATech Dr Dominik Escher, Chief Executive Officer	BioAxone Therapeutique Dr Frank Bobe, President & CEO	Manhattan Pharmaceuticals Douglas Abel, President & CEO
4:05 PM	Avidex James Noble, Chief Executive Officer	VIRxSYS Corporation Dr Riku Rautsola, Chief Executive Officer	Aethlon Medical James Joyce, Chairman & CEO
4:20 PM	immatics biotechnologies Dr Niels Emmerich, Managing Director	Ensemble Discovery Corporation Richard Begley, President & CEO	Advaxis John Rothmam, VP Clinical Development & Roni Appel, Chief Executive Officer
4:35 PM	Sapphire Therapeutics Gary Cupit, President & CEO	Glycoform Michael Short, Chief Executive Officer	Meditech Research Ian Nisbert, Chief Executive Officer
4:50 PM	BioVex Dr Tony Mills, VP Business Development	ConjuGon Salvatore Braico, Chief Operating Officer	Stressgen Gregory McKee, President & CEO
5:05 PM	Astex Therapeutics Dr Harrren Jhoti, Chief Scientific Officer & Acting CEO	Ingenium Pharmaceuticals Michael Grau, Chief Financial Officer	Allergy Therapeutics Keith Carter, Chief Executive Officer

Day Two: 14th March 2006
	Venture Funded Early to Mid Stage Company Presentations
	Ballroom Foyer: MIXED SESSION Chair: Peter Kalinka, Accelsiors Group	Venetian Room: Therapeutics Chair: Donna LaVoie, LaVoie Strategic Communications	Ballroom: Therapeutics Chair: William C Mills III, EGS Healthcare
1:40 PM	Smart Holograms Dr Michael Powell, President	DeveloGen Dr Guenther Karmann, Chief Executive Officer	Zealand Pharma Dr Eva Steiness, Chief Financial Officer
1:55 PM	Apoxis Dr George Bates, Chief Financial Officer	DiaKine Therapeutics Keith Ignotz, President & CEO	Topigen Dr Paul Wotton, President & CEO
2:10 PM	Thomsen Bioscience Dr Wolfgang Pieken, Partner	Santhera Dr Klaus Schollmeier, Chief Executive Officer	Affitech Dr Rathin C Das, Senior VP & Head of Corporate and Business Development
2:25 PM	Agendia Dr Bernhard Sixt, Chief Executive Officer	Targanta Therapeutics Dr Pierre Etienne, President & CEO	NOXXON Pharma Thomas Klein, Chief Executive Officer

test